Raaj Medisafe India Limited has scheduled its 41st Annual General Meeting (AGM) for Monday, September 21, 2026. The meeting will be conducted through video conference or other audio-visual means at 3:00 pm.

The company disclosed this intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 36(1)(b), electronic copies of the AGM notice and the Annual Report for FY26 are being emailed to shareholders with registered addresses. Those without registered emails have been sent letters containing a weblink to access the documents.

Financial Performance

Raaj Medisafe reported a 28.19% increase in turnover to ₹800,146.42 lakh for FY26, up from ₹624,204.43 lakh in FY25. However, net profit fell sharply to ₹18,097.90 lakh from ₹61,312.44 lakh in the previous year. Earnings per share dropped to ₹1.10 from ₹4.60.

The decline in profitability was primarily driven by a significant deferred tax charge of ₹34,572.00 lakh, compared to a deferred tax credit of ₹18,246.30 lakh in FY25. Profit before tax rose 20.31% to ₹63,223.12 lakh.

Key Dates and Voting Details

Central Depository Services (India) Limited will facilitate e-voting and the video conferencing facility. Shareholders must note the following timeline for participation:

The Register of Members, Beneficial Owners and Share Transfer Books of the Company will remain closed from Tuesday, September 15, 2026 to Monday, September 21, 2026 (both days inclusive).

Board Resolutions and Related Party Transactions

The AGM agenda includes ordinary business items such as the adoption of audited financial statements for the year ended March 31, 2026, and the re-appointment of Shri Arpit Bangur as a Director. He retires by rotation and is eligible for re-appointment.

A special resolution seeks shareholder consent for Smt. Krishna Jajoo to continue as a Non-Executive Non-Independent Director beyond attaining the age of 75 years on March 28, 2027, pursuant to Regulation 17(1A) of the SEBI Listing Regulations.

The Board also seeks approval for material related party transactions during FY27:

• Shriji Polymers (India) Limited: Up to ₹1,800 lakh for the purchase of raw materials and sale of plastic liners. Previous transactions in FY26 totaled ₹1,139.42 lakh.
• Shriniwas Polyfabrics and Packwell Private Limited: Up to ₹2,700 lakh for the purchase of raw materials and sale of extruded poly films. Previous transactions in FY26 totaled ₹1,799.33 lakh.

These transactions are proposed on an arm's length basis in the ordinary course of business.

Accessing Annual Report and KYC Updates

Shareholders whose email addresses are not registered with the Company, Registrar & Transfer Agent (RTA), or Depository Participants can access the FY26 Annual Report and AGM notice on the company’s website under Investor Relations > Annual Reports. The documents are also available on the BSE Limited website.

The company requested members holding shares in physical mode to update their email addresses by writing to investor@ankitonline.com or raajmedisafe@gmail.com . Demat shareholders are advised to update their details with their respective Depository Participants.

Physical share holders are asked to ensure their Folio KYC is compliant by submitting Forms ISR-1, ISR-2, ISR-4, SH-13, and SH-14 along with original Share Certificates and a CML not older than two months to the RTA, Ankit Consultancy Pvt Ltd., in Indore. These forms are available on the company’s website.

Raaj Medisafe India Limited reported a significant turnaround in profitability for the first quarter of FY27, with net profit rising 35% year-on-year to ₹197.37 lakh. The Ujjain-based manufacturer of plastic products and hygiene items saw its revenue from operations surge 86% to ₹2,945.91 lakh against ₹1,582.70 lakh in Q1FY26. This performance contrasts sharply with the preceding quarter (Q4FY26), where the company posted a net loss of ₹322.63 lakh.

The Board of Directors approved the unaudited financial results in its meeting held on August 12, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by statutory auditors GDK & Associates, who issued their report on the same date.

Financial Performance Overview

Revenue growth was broad-based across the company’s two reportable segments: Plastics and Hygiene. The Plastics Division, which manufactures bottles, caps, and liners, generated segment revenue of ₹2,112.00 lakh, up from ₹1,162.56 lakh in Q1FY25. The Hygiene Division, dealing in sanitary napkins and diapers, reported segment revenue of ₹851.17 lakh, doubling from ₹422.90 lakh in the prior year.

Expenses rose in tandem with revenue, increasing 87.7% to ₹2,697.23 lakh. Cost of materials consumed stood at ₹2,129.76 lakh, while employee benefits expense increased to ₹165.22 lakh from ₹113.25 lakh. Finance costs were contained at ₹86.36 lakh, down from ₹107.97 lakh in the previous quarter but higher than ₹68.13 lakh in Q1FY26.

Segmental Insights

The Plastics Division remained the primary profit driver, contributing ₹350.74 lakh to segment results, a sharp recovery from ₹105.96 lakh in Q4FY26 and an improvement over ₹178.18 lakh in Q1FY25. The Hygiene Division reported a segment result of ₹31.08 lakh, down significantly from ₹172.22 lakh in the previous quarter but up from ₹77.47 lakh in Q1FY25.

Total assets increased to ₹12,592.40 lakh as on June 30, 2026, from ₹12,134.87 lakh at the end of FY26. The Plastics Division accounted for ₹7,174.99 lakh of total assets, while the Hygiene Division held ₹5,385.41 lakh.

What the Numbers Show

A notable divergence exists between top-line growth and bottom-line expansion. While revenue surged 86% year-on-year, net profit grew only 35%. This indicates that operating margins contracted during the quarter. Specifically, cost of materials consumed grew disproportionately faster than revenue, suggesting pressure on gross margins or a shift in product mix towards lower-margin items. Additionally, other income jumped to ₹15.45 lakh from negligible levels in the prior year, contributing to the pre-tax profit but not offsetting the margin compression from core operations.